Key points are not available for this paper at this time.
Abstract The nickel‐catalyzed cross‐coupling of bromodifluoromethylphosphonates with arylboron reagents was developed with a 1,10‐phenanthroline‐type ligand. In this process, functionalized and heterocycle‐containing boroxines were found to be suitable partners, and the catalytic modification of biologically active molecules, such as fenofibrate and indomethacin, was also successfully achieved. Furthermore, the gram‐scale reaction smoothly proceeded to give the desired product in a high yield. magnified image
Kuriyama et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: